Interpret the DXA results (lumbar spine BMD 1.069 g/cm², T‑score ‑1.3; left femoral neck BMD 0.775 g/cm², T‑score ‑2.3; left total hip BMD 0.851 g/cm², T‑score ‑1.7) and FRAX 10‑year major osteoporotic fracture risk 4.3 % and hip fracture risk 1.1 % for a man aged 50 years or older, and provide management recommendations.

DXA Interpretation and Management Recommendations

Direct Answer

Based on your DXA results showing low bone mass (osteopenia) with a femoral neck T-score of -2.3 and low FRAX scores (4.3% major fracture risk, 1.1% hip fracture risk), you do not currently meet criteria for pharmacological treatment according to International Society for Clinical Densitometry guidelines, and this interpretation is correct 1.

Detailed Interpretation of Your Results

BMD Classification by Site

Your results show low bone mass (osteopenia) at all measured sites:

• Lumbar spine (L1-L4): T-score -1.3 (mild osteopenia)
• Left femoral neck: T-score -2.3 (moderate osteopenia, approaching osteoporosis threshold of -2.5)
• Left total hip: T-score -1.7 (moderate osteopenia)

The femoral neck is your most concerning site with a T-score of -2.3, which is just 0.2 points away from meeting the WHO definition of osteoporosis 1, 2.

FRAX Risk Assessment

Your 10-year fracture probabilities are:

• Major osteoporotic fracture: 4.3% (below treatment threshold)
• Hip fracture: 1.1% (below treatment threshold)

Treatment Threshold Analysis

You do not meet pharmacological treatment criteria because:

1. No T-score ≤ -2.5 (osteoporosis threshold) at any site
2. FRAX scores below intervention thresholds: For men ≥50 years, treatment is typically recommended when FRAX shows ≥3% hip fracture risk OR ≥20% major osteoporotic fracture risk 3. Your scores (1.1% and 4.3%) fall well below these thresholds.
3. No prior fragility fracture documented

The European guidance supported by multiple international organizations uses age-specific probability thresholds, and your absolute fracture risk remains in the low-risk category 1.

Critical Clinical Considerations

Why the Femoral Neck Matters Most

The femoral neck T-score of -2.3 deserves particular attention because:

• Hip BMD measurements show stronger predictive accuracy for hip fractures (AUC 0.64-0.86) compared to spine measurements 2
• In men, hip T-scores are typically lower than lumbar scores and decrease more consistently with aging 4
• The gradient of fracture risk per unit decrease in BMD is similar between men and women 1

Z-Score Interpretation

Your Z-scores (-1.5 to -2.2) indicate your bone density is 1.5 to 2.2 standard deviations below age-matched peers. Z-scores ≤ -2.0 at the femoral neck and total hip suggest you should be evaluated for secondary causes of osteoporosis, including:

• Vitamin D deficiency
• Hypogonadism (testosterone levels)
• Hyperthyroidism or hyperparathyroidism
• Chronic glucocorticoid use
• Excessive alcohol consumption
• Malabsorption disorders
• Chronic kidney disease

Management Recommendations

Immediate Actions

1. Screen for secondary causes given Z-scores ≤ -2.0:

   • Serum 25-hydroxyvitamin D
   • Serum testosterone (total and free)
   • TSH, serum calcium, phosphate
   • Complete blood count, comprehensive metabolic panel
   • Consider 24-hour urine calcium if indicated

2. Optimize non-pharmacological interventions:

   • Ensure adequate calcium intake (1000-1200 mg/day from diet ± supplements)
   • Vitamin D supplementation to achieve serum 25(OH)D ≥30 ng/mL
   • Weight-bearing and resistance exercise
   • Fall prevention strategies
   • Smoking cessation if applicable
   • Limit alcohol to ≤2 drinks/day

Follow-Up Strategy

Repeat DXA in 1-2 years to assess:

• Rate of bone loss (this scan serves as your baseline)
• Whether you cross the osteoporosis threshold (T-score ≤ -2.5)
• Changes in FRAX risk assessment

Earlier reassessment warranted if:

• You sustain a fragility fracture
• You develop conditions requiring chronic glucocorticoid therapy
• Secondary causes of bone loss are identified

When to Reconsider Pharmacological Treatment

Treatment should be initiated if:

• T-score drops to ≤ -2.5 at any site
• You sustain a fragility fracture (fracture from standing height or less)
• FRAX scores increase to ≥3% hip fracture risk or ≥20% major fracture risk
• Rapid bone loss documented on serial DXA (>3-5% decline at spine or >5-6% at hip beyond measurement error)

Common Pitfalls to Avoid

• Do not ignore the femoral neck T-score simply because the spine appears better; in men, hip measurements are more clinically relevant 4
• Do not assume you're "safe" indefinitely; bone loss can accelerate, particularly if secondary causes develop
• Do not overlook secondary causes when Z-scores are ≤ -2.0
• Do not rely solely on calcium/vitamin D supplements as fracture prevention—while important for bone health, evidence for fracture reduction in community-dwelling men without deficiency is limited 2